These observations support the idea that KLF2 loss results in increased NET formation and thrombosis in the microvasculature, which in turn leads to localized myocardial ischemia, cell death, and microvascular rarefaction (Figure 1), phenomena that have been associated with cardiac hypertrophy (1, 14–16). This evidence concerns the gene KLF2 and cardiac hypertrophy.